Concert Pharmaceuticals

AstraZeneca Gets Central Drugs Standard Control Organisation Approval For Durvalumab In Gastric Cancer Treatment

AstraZeneca Gets Central Drugs Standard Control Organisation Approval For Durvalumab In Gastric Cancer Treatment

BY PTI

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

Sun Pharma To Acquire Concert Pharmaceuticals In $576 Million Deal

BY Press Trust of India